Results 141 to 150 of about 6,549 (182)
Some of the next articles are maybe not open access.
Radioembolization for Cholangiocarcinoma
Digestive Disease Interventions, 2021AbstractCholangiocarcinoma is the second most common primary hepatic malignancy which accounts for 13% of total cancer mortality worldwide. Surgical resection is the only curative treatment for localized disease; however, the majority of patients present when the tumor is unresectable.
Aamir Ali +5 more
openaire +1 more source
Regional Infusion-Radioembolization
Surgical Oncology Clinics of North America, 2008Selective internal radiation therapy involves the intra-arterial delivery of radioactive beads to the tumor while minimizing dosing to the adjacent organ. Because this technique invariably results in some degree of embolization, it has also been termed radioembolization.
Gregory J, Dubel, Gregory M, Soares
openaire +2 more sources
Radioembolization of Secondary Hepatic Malignancies
Seminars in Interventional Radiology, 2021AbstractCancer has become the leading cause of mortality in America, and the majority of patients eventually develop hepatic metastasis. As liver metastases are frequently unresectable, the value of liver-directed therapies, such as transarterial radioembolization (TARE), has become increasingly recognized as an integral component of patient management.
Barbara, Manchec +7 more
openaire +2 more sources
Transarterial Chemoembolization and Radioembolization
Seminars in Liver Disease, 2014Transarterial chemoembolization (TACE) and radioembolization (RE) are frequently used to treat patients with hepatocellular carcinoma who cannot receive curative therapies. Transarterial chemoembolization is a heterogeneous group of procedures; based on two positive clinical trials and three meta-analyses, conventional TACE is the standard of care for ...
Bruno, Sangro, Riad, Salem
openaire +2 more sources
Radioembolization for hepatic metastases
Seminars in Oncology, 2002In a phase I/II study, 37 patients with metastatic liver disease, predominantly from colorectal cancer (n = 33) were treated between 1986 and 1994 by intrahepatic arterial embolization of radioactive yttrium 90 (Y 90) glass microspheres. The calculated total liver dose increased in stages from 5,000 cGy to 15,000 cGy. Mean follow-up was 8 months (range,
Milton J, Herba, Michael P, Thirlwell
openaire +2 more sources
Radioembolization in the Setting of Systemic Therapies
Seminars in Interventional Radiology, 2021Abstract 90Yttrium (Y90) radioembolization has been shown to improve outcomes for primary and metastatic liver cancers, but there is limited understanding of the optimal timing and safety of combining systemic therapies with Y90 treatment.
Tarub S, Mabud, Ryan, Hickey
openaire +2 more sources
Radioembolization in liver tumors
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2019The detection of malignant liver tumours is recently increasing. These lesions have frequently arterial vascularization which differs from healthy parenchyma with main portal flow making them especially susceptible to transarterial therapies. Transarterial Radioembolization (TARE) is an emerging treatment for the management of different liver tumours ...
L, Carrion-Martin +6 more
openaire +2 more sources
Chemoembolization and radioembolization
Best Practice & Research Clinical Gastroenterology, 2014Chemoembolization and radioembolization are at the core of the treatment of patients with hepatocellular carcinoma who cannot receive potentially curative therapies such as transplantation, resection or percutaneous ablation. They differ in the mechanism of action (ischaemia and increase cytotoxic drug exposure for chemoembolization, internal ...
openaire +2 more sources
Radioembolization of Hepatocellular Carcinoma
Current Drug Discovery Technologies, 2010In this review paper, available data on radioembolization of unresectable hepatocellular carcinoma (HCC) using commercially available radiopharmaceuticals, respectively (131)I-Lipiodol, Therasphere (glass-microspheres) and SIRspheres (resin-microspheres) are reviewed. In the palliative setting, (131)I-Lipiodol was shown to yield response rates of 17-92%
openaire +2 more sources
Radioembolization and the Cystic Artery
Journal of Vascular and Interventional Radiology, 2014Based on a review of the literature about the topic and personal experience obtained in several years performing radioembolization, if I have to answer the question posed by Prince et al (1), I will arrive at a very similar conclusion as the authors: Yes, we need to take precautionary measures with RE, as we always do when performing an interventional ...
openaire +2 more sources